Financial Year |
March 31 2023 |
Monetary Funds |
158,752,700.30 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
14,041,083.68 |
Accounts Receivable |
342,620,747.58 |
Advances to Suppliers |
11,920,218.04 |
Other Receivables |
1,818,083.95 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
331,328,804.42 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
994,177.87 |
Total Current Assets |
959,907,744.83 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
952,948,731.34 |
Under-construction Projects |
155,869,387.60 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
68,058,892.55 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
11,045,061.61 |
Other Non-Current Assets |
2,737,628.64 |
Sub-Total of Non-Current Assets |
1,195,784,831.27 |
Total Assets |
2,155,692,576.10 |
Short-Term Loans |
464,742,497.70 |
Trading Financial liabilities |
-- |
Notes Payable |
78,214,489.97 |
Accounts Payable |
147,418,886.94 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
23,968,583.16 |
Taxes Payable |
12,887,652.05 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
17,091,952.70 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,159,905.53 |
Other Current Liabilities |
67,246.31 |
Sub-Total of Current Liabilities |
776,240,156.79 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
51,062,654.79 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
98,132,115.19 |
Total Liabilities |
874,372,271.98 |
Paid-In Capital(Or Share Stock) |
203,290,636.00 |
Capital Surplus |
526,226,468.20 |
Surplus Reserve |
56,208,417.49 |
LESS:Treasury Stock |
12,798,173.60 |
Undistributed Profits |
434,876,276.89 |
Minority Stockholder's Interest |
73,516,679.14 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,207,803,624.98 |
Owner's Equity(Stockholder's Equity) |
1,281,320,304.12 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,155,692,576.10 |